Prostate drug levels checked in tiny study
NCT ID NCT02041767
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study gave 20 men with enlarged prostates a single dose of the antibiotic ertapenem before their scheduled prostate surgery. Researchers then measured how much of the drug actually reached the prostate tissue. The goal was to see if a pre-surgery dose could provide enough antibiotic to prevent infections, but the study only looked at drug levels, not infection rates.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ertapenem (antibiotic)
- What this could lead to
- If successful, this could show that a single pre-surgery dose of ertapenem reaches high enough levels in the prostate to help prevent infections after prostate surgery.
- What could go wrong
- This is a very small, early-phase study (20 participants) that only measures drug levels, not whether it actually prevents infections. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN PROSTATIC HYPERPLASIA (BPH) REQUIRING SURGICAL RESECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
HEGP Hospital
Paris, 75908 Cedex 15, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.